LABU

Direxion Daily S&P Biotech Bull …

171.64

+2.01+1.18%

After Hours: 169.95 -1.69 -0.98%19:59 04/02 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE158.65/169.63

TODAY RANGE157.65-174.86

VOL715.31K

TOTAL ASSET509.79M

52 WEEK RANGE32.22-198.18

% TURNOVER0%

NAV171.39

EXPENSE RATIO(NET)0.96%

1Y RETURN(CUM.)191.18%

DIVIDEND1.231

DIV YIELD0.72%

EX-DATE03/24/2026

% RANGE10.03%

INCEPTION DATE05/28/2015

BETA--

LOT SIZE1

LIPPER RATING-

News

Seeking Alpha·03/08 18:42
The K-Shaped Consumer Economy: GLP-1s, AI And The Future Of Consumer Spending
Seeking Alpha·03/06 09:00
The Trump Administration's Affordability Plan
Seeking Alpha·03/01 16:30
Leveraged ETF Watchlist And Focus On SPXU History
Seeking Alpha·02/26 11:56
Q1 Active Management Pulse: Positioning Broadens Beyond AI Leaders
Seeking Alpha·02/01 17:05
Measuring UDOW's Drift, And Leveraged ETF Watchlist
Seeking Alpha·01/29 04:50
The Diversification Role Mid-Cap Stocks Can Play
Seeking Alpha·01/26 14:19
LABD: ETF To Benefit From Downturns In The Biotech Industry
Seeking Alpha·01/22 11:07
Are Healthcare Stocks Poised To Recover As Policy Fears Stabilize?
Seeking Alpha·01/20 17:39
CURE: Benefits And Caveats Of The Leveraged Healthcare ETF
NASDAQ·01/15 16:46
Notable ETF Outflow Detected - LABU, RVMD, MRNA, KRYS
Seeking Alpha·01/08 10:30
Healthcare Stocks In Focus: Assessing The Outlook For 2026
Seeking Alpha·01/02 15:04
Leveraged ETF Drift Watch List And Focus On SQQQ
Seeking Alpha·12/19/2025 08:10
Key Takeaways From Equity Earnings Calls: Q3 2025
Seeking Alpha·12/17/2025 17:29
LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF
Seeking Alpha·12/03/2025 06:00
SEC warns Direxion, ProShares, and Tidal, stalling new leveraged ETF launches

Same Industry

Name/Symbol

Change%

Price

No data yet, let's see others

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.